would enable the first dose of dantrolene to be administered in a much faster time interval than in the current system; this could save patients by reducing associated mortality and morbidity. In addition, patients who express some symptoms and signs that are similar to malignant hyperthermia may not be confirmed as cases of malignant hyperthermia. Therefore, an additional system should be prepared to enable prompt patient transfer to the malignant hyperthermia center; moreover, the caffeine-halothane contracture test and gene test should be available, which can be used for diagnosis and further assistance of patients and their families. This would facilitate prevention of malignant hyperthermia in the future and provide necessary information to the medical providers.
We think that a properly equipped malignant hyperthermia center is essential to confirm diagnosis and support affected patients in Korea.
